prr v dndn, page-10

When we talk about Nasdaq listing and interest from the U.S. it amazes me that in good old Australia the penny still hasn't dropped. Should we be surprised, probably not. As I have mentioned before, Australian investors seem to be willing to seperate themselves with so much of their hard earned cash for a company 'looking' for some type of mineral, but not for a once in a lifetime cancer vaccine investment.

When K. Rudd became PM, what was one of the first things he did. He cut the grant for biomed sector working at developing cures and treatments....Prima had guaranteed grants disappear when they needed them most. I would love to tell Labour when to shove their policies, but think you get the picture.

Why wouldn't U.S. investors be interested in 'OUR' Prima. When we have lacked faith, shown disinterest or prefered other investments because we are an impatient bunch, their Dendreon has skyrocketed on a single product which 'apparently' treats one form of cancer. Hopefully this is not the case and it is successful on others.

Will U.S. investors see that Prima has already completed phase II trials (NB. 0n a smaller scale but on a much more progressed patient group). Yes, I believe they will. Cvac will not hurt anyone. Phase IIb is a given.

I agree with other posters who say U.S. investors are more averse to the Bio sector risk and willing to invest heavily where Australian investors are reluctant, but they are not stupid. They research and compare companies and to compare Dendreon and Prima, although relevant is far to complicated at this point.

Shares on issue at each stage and funds in the bank,let alone the differences and similarities in treatments make it very very complex. As investors in Prima, we should all be proud that we are suportes of an Australian business about to list on the Nasdaq. I just can't wait until I watch the Business Channel and see Prima Biomed scroll across the bottom of the screen as one of the asx200.

Lately, it is obvious there are many new investors to Prima Biomed, and to them I say welcome. To the long termers I say congatulations. People will take profit while other ask questions we have seen the answer to (what feels like) a thousand times.

We need to accept both and welcome a new chapter to Prima Biomed. I truely believe we may be on the verge of being investors of a company that will change all our lives, even if it is just a little. For the patients it is life changing in another way. It means so much to those who have nothing else but hope, and for them I truely wish Cvac brings them what they wish for.

The future is very bright for Prima but it will not be without its trials. I wish everyone all what they wish for and for those who decide to take profit I congratulate you. It is a hard decision when you are faced with so much positivity.

This is my rant and good luck to all investors. We have seen a fantastic few weeks and look forward to some exciting and interesting times. Who would have thought some years ago, with the interesting and sometimes shattering times Prima has experienced that we would be looking at our imminant Nasdaq listing.

Good luck and regards to all.

dc